ATX1 antibodies are designed to bind ATX1 proteins, which differ functionally across species:
Dual Regulatory Role: ATX1 activates ~780 genes and represses ~860 genes in Arabidopsis, impacting transcription factors, stress responses, and development .
Mechanistic Insights:
Binds phosphatidylinositol 5-phosphate (PI5P), linking lipid signaling to chromatin remodeling .
Facilitates RNA Polymerase II elongation by establishing H3K4me3 marks downstream of transcription start sites .
Regulates drought-responsive genes (e.g., WRKY70, NCED3), with 30% of targets encoding plasma membrane/cell wall functions .
Copper Chaperone Activity: Delivers Cu(I) to post-Golgi vesicles for iron uptake oxidase assembly, critical under iron-limited conditions .
Antibody Validation: Knockdown (ami-atx1) and knockout (atx1-1, atx1-2) lines confirmed ATX1’s role in growth during iron deficiency .
Neurodegeneration: Mutant Ataxin-1 (polyglutamine-expanded) interacts with SMRT/HDAC3 repressors, causing transcriptional dysregulation in spinocerebellar ataxia .
Subcellular Localization: Ataxin-1 associates with splicing factors (e.g., U2AF65) and forms nuclear aggregates linked to toxicity .
Western Blotting: Used to assess ATX1 expression in Chlamydomonas under iron-limited conditions .
Chromatin Immunoprecipitation (ChIP): Identified ATX1-binding regions at H3K4me3-enriched loci in Arabidopsis .
Immunofluorescence: Localized Ataxin-1 to nuclear aggregates in human cell models .
Cross-Reactivity: Antibodies like PHY1582S are specific to Chlamydomonas ATX1, with no cross-reactivity reported in Arabidopsis or human systems .
Batch Consistency: Recombinant monoclonal antibodies (e.g., 83785-1-PBS) ensure high reproducibility for quantitative assays .
References:
Perform Western blot with atx1 knockout mutants as negative controls (wild-type vs mutant comparisons)
Use peptide blocking assays: Pre-incubate antibody with immunogen peptide to test signal disappearance
Combine with mass spectrometry verification of immunoprecipitated proteins
Recommended controls:
| Control Type | Purpose | Expected Result |
|---|---|---|
| Wild-type tissue | Positive signal | Clear band at ~150 kDa (full-length ATX1) |
| atx1 mutant | Specificity test | No band at 150 kDa |
| Secondary antibody-only | Background check | No bands |
Fixation method: Use fresh formaldehyde (1-2%) for nuclear-cytoplasmic localization preservation
Developmental stage: Localization shifts occur between:
Phospholipid interactions: PI5P treatment causes nuclear-to-cytoplasmic relocalization within 95 mins
3. Resolving contradictory data on ATX1's transcriptional roles
Context: ATX1 shows both activation (H3K4me3 deposition) and repression functions
Experimental approach:
Identification steps:
Optimized parameters:
Workflow:
Sort cell types using FACS (e.g., interfascicular fibers vs xylem)
Parallel processing:
10% cells for H3K4me3 ChIP-seq
90% cells for scRNA-seq
Key finding: 26/107 ATX1-direct targets show stage-specific hypermethylation